Search

Milan Gerovac (University of Würzburg) and colleagues published a new paper revealing how phage-encoded proteins, particularly from jumbo phage ΦKZ, target and co-opt P. aeruginosa ribosomes immediately after infection. They make the case t

The CDC has launched an Antimicrobial Resistance Investment Map (interestingly, they are calling it ‘AR’ now — is this our new acronym for AMR?). The map illustrates the allocation of CDC funds in the US and abroad. Explore funding landscap

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is offering funding for Phase II or III clinical trials focusing on antimicrobial agents for multi-resistant Gram-negative bacilli infections. Application deadline

This week we're highlighting a brand new paper out of the Bordenstein lab, out yesterday in Science, that unravels the mechanism by which prophage-encoded proteins control whether Drosophila flies reproduce or not. This week things take a d

Little is known about the interactions between phages and bacteria in densely packed and spatially structured biofilm communities. The River Ecosystems Laboratory at EPFL, Switzerland is hiring a postdoc to study interactions between phages

FDA (Silver Spring, Maryland) is offering a postbac fellowship to develop and characterize phage therapy for decolonizing Vancomycin-resistant Enterococci, focusing on overcoming bacterial resistance.

In a recent podcast episode of This Week in Virology (TWiV), learn how a viral capsid protein activates a bacterial innate immune system, interfering with protein synthesis, and human-associated redondoviruses that infect the commensal prot

In another recent TWiV episode, learn how mammalian cells internalize and utilize phage particles to enhance cell growth and survival.

BiomX and Adaptive Phage Therapeutics have announced they will merge! They concurrently announce new financing of $50 million, which will help advance the combined company’s two Phase 2 assets: one for CF and one for diabetic foot ulcers.

Armata Pharmaceuticals has announced a $35 million credit agreement with its largest shareholder, Innoviva.

The UK government has responded to the Science, Innovation, and Technology Committee's report on the antimicrobial potential of phages, outlining recommendations for assessing the safety and effectiveness of phages in healthcare settings.

Owen Tuck and colleagues have discovered the Hachiman defense system, a broad-spectrum antiphage defense system, activates in response to DNA damage, creating 'phantom' cells devoid of both phage and host DNA. Preprint | Tweet thread

Attention phage researchers! The Felix d'Herelle Center is calling for deposits of characterized phages to ensure permanent archiving and prevent loss when research projects end. Have you considered depositing your lab's collection?

We are urgently seeking Achromobacter phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We are urgently seeking Achromobacter phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We are urgently seeking Achromobacter phages for a patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spre

We're starting off the year by trying a new format: Phage Picks — where we share the papers we keep bookmarked... and keep coming back to. Hi everyone! We thought we'd kick off the year with a new format. We've been reading phage papers

EPFL (Lausanne, Switzerland) is hiring a postdoc to explore phage-bacteria interactions within stream biofilms using microfluidic techniques.

UC San Diego is hiring a Staff Research Associate to design and construct jumbo phage genomes for new phage production, involving computational design, synthetic biology, and yeast genetics.

University of Nottingham, UK, is offering a PhD Studentship to develop phage therapy strategies against C. difficile, involving synthetic biology, CRISPR/Cas genome editing, and microbiology.